amlodipine has been researched along with aldosterone in 52 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 5 (9.62) | 18.2507 |
2000's | 21 (40.38) | 29.6817 |
2010's | 20 (38.46) | 24.3611 |
2020's | 6 (11.54) | 2.80 |
Authors | Studies |
---|---|
Buckley, MG; Cappuccio, FP; MacGregor, GA; Markandu, ND; Miller, MA; Sagnella, GA; Singer, DR | 1 |
Arosio, E; Campedelli, A; Degan, M; Lechi, A; Minuz, P; Pancera, P; Priante, F; Ribul, M | 1 |
Cerci, S; Coassin, S; De Ciocchis, A; Fisher, H; Letizia, C; Scavo, D; Tarsitani, P | 1 |
Chang, SM; Chou, TC; Ding, YA | 1 |
Kokot, F; Kokot, M; Witkowicz-Kulhawik, J | 1 |
Antonios, TF; He, FJ; MacGregor, GA; Viskoper, JR | 1 |
Kataoka, H; Kishida, M; Makino, H; Mimura, Y; Ogura, T; Otsuka, F; Takahashi, M; Yamauchi, T | 1 |
Darné, B; Démolis, JL; Funck-Brentano, C; Jaillon, P; Ragueneau, I; Sao, AB | 1 |
Kataoka, H; Kishida, M; Makino, H; Mimura, Y; Nakamura, Y; Ogura, T; Otsuka, F; Takahashi, M; Yamauchi, T; Yokota, K | 1 |
Chiandussi, L; Milan, A; Morello, F; Mulatero, P; Paglieri, C; Rabbia, F; Veglio, F | 1 |
Fujii, M; Hayashi, M; Ishii, C; Maeda, K; Ohnishi, M; Tsutamoto, T; Tsutsui, T; Wada, A | 1 |
Kawecka-Jaszcz, K; Klocek, M; Rajzer, M | 1 |
Castro, I; Reis, FM; Ruschel, S; Spritzer, PM; Vilodre, LC; Vitola, D; Wender, MC | 1 |
Hukai, D; Ishii, C; Kanamori, T; Ohbayashi, Y; Ohnishi, M; Ohno, K; Okabayashi, T; Ozawa, T; Sakaguchi, T; Sichiri, G; Tanaka, T; Tsutamoto, T; Tsutsui, T; Wada, A; Yokohama, H | 1 |
Alexander, GJ; Brown, MJ; Byrne, CD; Neal, DA; Wilkinson, IB | 1 |
de Champlain, J; Karas, M; Lacourcière, Y; Lamarre-Cliche, M; Larochelle, P; Poirier, L | 1 |
Akashiba, A; Ishimitsu, T; Kameda, T; Matsuoka, H; Minami, J; Numabe, A; Ohta, S; Ono, H; Takahashi, T; Yoshii, M | 1 |
Atkins, CE; Defrancesco, TC; Gardner, SY; Keene, BW; Levine, JF; Rausch, WP | 1 |
Fujii, M; Horie, M; Sakai, H; Tanaka, T; Tsutamoto, T; Yamamoto, T | 1 |
Appleton, DS; Brown, MJ; Mir, FA | 1 |
Beevers, DG; Harding, LK; Maheshwari, MB; Moss, MS; Ryan, PG | 1 |
Aritomi, S; Enomoto, A; Koganei, H; Konda, T; Niinuma, K; Nitta, K; Ogawa, T | 1 |
Ahokas, RA; Baburyan, NY; Bhattacharya, SK; Deshmukh, PA; Gandhi, MS; Gerling, IC; Johnson, PL; Kamalov, G; Sun, Y; Weber, KT | 1 |
Fujii, M; Horie, M; Kawahara, C; Nishiyama, K; Tanaka, T; Tsutamoto, T; Yamaji, M; Yamamoto, T | 1 |
Antikainen, M; Donner, KM; Hannila-Handelberg, T; Hiltunen, TP; Hirvonen, A; Kontula, K; Suonsyrjä, T; Tikkanen, I | 1 |
Ban, N; Endo, K; Kawana, H; Miyashita, Y; Nagayama, D; Ohhira, M; Oyama, T; Saiki, A; Sasaki, H; Shirai, K; Yamaguchi, T | 1 |
Inada, H; Ishimitsu, T; Matsuoka, H; Nakano, N; Ohba, S; Okamura, A; Takahashi, T | 1 |
Arakawa, K; Fujii, M; Inoki, I; Kimura, T; Konoshita, T; Makino, Y; Miyamori, I; Nakamura, H; Wakahara, S | 1 |
Chen, C; Ding, G; Hu, F; Liang, W; Ren, Z; Shi, J; Singhal, PC; van Goor, H | 1 |
Goda, A; Hirotani, S; Lee-Kawabata, M; Masuyama, T; Matsumoto, M; Naito, Y; Nakaboh, A; Ohyanagi, M; Otsuka, M; Tsujino, T; Yoshida, C | 1 |
Fujita, H; Harasawa, S; Hirayama, A; Koike, M; Kushiro, T; Nagao, K; Okubo, K; Otsuka, Y | 1 |
Abe, M; Fujita, T; Maruyama, N; Maruyama, T; Matsumoto, K; Matsumoto, S; Okada, K; Soma, M | 1 |
Cho, JY; Jang, IJ; Kim, TE; Shin, SG; Yi, S; Yoon, SH; Yu, KS | 1 |
Dong, YF; Fukuda, M; Kataoka, K; Kim-Mitsuyama, S; Nakamura, T; Nako, H; Ogawa, H; Tokutomi, Y; Yamamoto, E; Yasuda, O | 1 |
Chen, S; Cui, Y; Jiang, J; Peng, J; Shen, J; Wang, W; Wu, Q | 1 |
Abe, M; Fujii, Y; Ito, M; Maruyama, N; Okada, K; Soma, M; Suzuki, H; Yoshida, Y | 1 |
Abe, M; Inoshita, A; Maruyama, N; Okada, K; Soma, M; Suzuki, H; Yoshida, Y | 1 |
Matavelli, LC; Siragy, HM | 1 |
Lin, J; Lin, L; Peng, F; Tang, H | 1 |
Fujiwara, S; Fukui, M; Goda, A; Hirotani, S; Komamura, K; Koshiba, M; Lee-Kawabata, M; Masaki, M; Masuyama, T; Nakabo, A; Otsuka, M; Sugahara, M; Tsujino, T | 1 |
He, DH; Lin, JX; Lin, LM; Ning, RB; Wang, HJ; Xu, CS; Zhang, LM | 1 |
Elwood, C; Fryers, A | 1 |
Azizi, M; Bobrie, G; Chatellier, G; Frank, M; Ménard, J; Perdrix, L; Plouin, PF | 1 |
Fujii, M; Ichikawa, M; Imagawa, M; Ishizuka, T; Kaeriyama, S; Konoshita, T; Makino, Y; Nakamura, H; Nakaya, T; Sato, S; Suzuki, J; Urabe, M; Wakahara, S; Yamada, M; Yamamoto, K; Zenimaru, Y | 1 |
Akabane, R; Konta, M; Miyagawa, Y; Nagakawa, M; Sakatani, A; Takemura, N | 1 |
Bhurawala, H; Roffey, E | 1 |
Adler, GK; Green, JAEM; Hornik, ES; Koefoed, AW; Stone, IB; Williams, GH; Williams, JS | 1 |
Ashraf, H; Bahreini, M; Ghoghaei, M; Najmeddin, F; Rasooli, F; Salehi, M; Soleimani, A; Solhjoo, M | 1 |
Choi, MH; Gao, X; Ito, A; Morimoto, R; Motomura, N; Nakamura, Y; Omata, K; Ono, Y; Sasano, H; Satoh, F; Shim, J; Tezuka, Y; Yamazaki, Y | 1 |
Domenig, O; Guillot, E; Mochel, JP; Ward, JL; Ware, WA; Yuan, L | 1 |
Böhm, M; Götzinger, F; Hohl, M; Hübner, U; Lauder, L; Lehnert, U; Mahfoud, F; Meyer, MR; Schneider, C; Sevimli, Ö; Tokcan, M; Wagmann, L | 1 |
Hess, RS; Williams, JG | 1 |
30 trial(s) available for amlodipine and aldosterone
Article | Year |
---|---|
Effects of amlodipine on urinary sodium excretion, renin-angiotensin-aldosterone system, atrial natriuretic peptide and blood pressure in essential hypertension.
Topics: Aldosterone; Amlodipine; Atrial Natriuretic Factor; Blood Pressure; Calcium Channel Blockers; Female; Humans; Male; Middle Aged; Nifedipine; Renin; Renin-Angiotensin System; Sodium | 1991 |
Amlodipine and haemodynamic effects of cyclo-oxygenase inhibition.
Topics: 6-Ketoprostaglandin F1 alpha; Adult; Aldosterone; Amlodipine; Biomarkers; Blood Pressure; Creatinine; Cross-Over Studies; Cyclooxygenase Inhibitors; Epoprostenol; Heart Rate; Hemodynamics; Humans; Hypertension; Ibuprofen; Male; Middle Aged; Outpatients; Renin; Single-Blind Method; Thromboxane A2; Ultrasonography; Vascular Resistance; Vasodilator Agents | 1995 |
Amlodipine in ambulatory hypertensive patients: humoral and haemodynamic effects.
Topics: Adult; Aged; Aged, 80 and over; Albuminuria; Aldosterone; Amlodipine; Blood Pressure; Cholesterol; Female; Hemodynamics; Humans; Hypertension; Male; Middle Aged; Peptidyl-Dipeptidase A; Renin; Renin-Angiotensin System; Water-Electrolyte Balance | 1993 |
Comparison of amlodipine and quinapril on ambulatory blood pressure and platelet function in hypertension.
Topics: Adult; Aged; Aldosterone; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Platelets; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Calcium Channel Blockers; Cross-Over Studies; Double-Blind Method; Female; Heart Rate; Humans; Hypertension; Isoquinolines; Male; Middle Aged; Quinapril; Renin; Tetrahydroisoquinolines; Treatment Outcome | 1995 |
[Effect of 12-week treatment with amlodipine on plasma renin activity and adrenal cortex function in patients with essential hypertension].
Topics: Adult; Aldosterone; Amlodipine; Antihypertensive Agents; Female; Humans; Hydrocortisone; Hypertension; Male; Renin; Renin-Angiotensin System | 1997 |
Efficacy of candesartan cilexetil alone or in combination with amlodipine and hydrochlorothiazide in moderate-to-severe hypertension. UK and Israel Candesartan Investigators.
Topics: Aldosterone; Amlodipine; Analysis of Variance; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Blood Pressure Monitoring, Ambulatory; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Israel; Male; Middle Aged; Renin; Single-Blind Method; Tetrazoles; United Kingdom | 2000 |
Comparison of sympathetic modulation induced by single oral doses of mibefradil, amlodipine, and nifedipine in healthy volunteers.
Topics: Administration, Oral; Adult; Aldosterone; Amlodipine; Calcium Channel Blockers; Cross-Over Studies; Double-Blind Method; Electrocardiography; Epinephrine; Hemodynamics; Humans; Male; Mibefradil; Nifedipine; Sympathetic Nervous System | 2001 |
Drug effects on aldosterone/plasma renin activity ratio in primary aldosteronism.
Topics: Aldosterone; Amlodipine; Antihypertensive Agents; Atenolol; Biphenyl Compounds; Confounding Factors, Epidemiologic; Diagnostic Tests, Routine; Doxazosin; False Negative Reactions; False Positive Reactions; Fosinopril; Humans; Hyperaldosteronism; Hypertension; Irbesartan; Middle Aged; Predictive Value of Tests; Renin; Renin-Angiotensin System; Sensitivity and Specificity; Tetrazoles; Tomography, X-Ray Computed | 2002 |
Effect of amlodipine, quinapril, and losartan on pulse wave velocity and plasma collagen markers in patients with mild-to-moderate arterial hypertension.
Topics: Adult; Aldosterone; Amlodipine; Antihypertensive Agents; Biomarkers; Blood Flow Velocity; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Collagen; Compliance; Echocardiography; Elasticity; Female; Humans; Hypertension; Losartan; Male; Middle Aged; Pulsatile Flow; Quinapril; Severity of Illness Index; Tetrahydroisoquinolines | 2003 |
One year follow-up of hormone replacement therapy with percutaneous estradiol and low-dose vaginal natural progesterone in women with mild to moderate hypertension.
Topics: Administration, Cutaneous; Administration, Intravaginal; Aldosterone; Amlodipine; Antihypertensive Agents; Blood Pressure; Estradiol; Estrogen Replacement Therapy; Female; Heart Rate; Humans; Hypertension; Posture; Progesterone; Renin; Time Factors; Vagina | 2003 |
Effect of an angiotensin II type 1 receptor blocker, valsartan, on neurohumoral factors in patients with hypertension: comparison with a long-acting calcium channel antagonist, amlodipine.
Topics: Aged; Aldosterone; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Calcium Channel Blockers; Coronary Disease; Delayed-Action Preparations; Female; Heart Failure; Humans; Hypertension; Male; Middle Aged; Natriuretic Peptide, Brain; Neurotransmitter Agents; Norepinephrine; Receptor, Angiotensin, Type 1; Tetrazoles; Time Factors; Valine; Valsartan | 2003 |
Hemodynamic effects of amlodipine, bisoprolol, and lisinopril in hypertensive patients after liver transplantation.
Topics: Adult; Aged; Aldosterone; Amlodipine; Antihypertensive Agents; Bisoprolol; Cross-Over Studies; Female; Humans; Hypertension; Lisinopril; Liver Transplantation; Male; Middle Aged; Postoperative Complications; Renin; Treatment Outcome | 2004 |
Effects of circadian rhythms, posture, and medication on renin-aldosterone interrelations in essential hypertensives.
Topics: Adult; Aged; Aldosterone; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Benzoates; Calcium Channel Blockers; Circadian Rhythm; Female; Humans; Hyperaldosteronism; Hypertension; Male; Middle Aged; Posture; Prospective Studies; Ramipril; Reference Values; Renin; Renin-Angiotensin System; Telmisartan; Treatment Outcome | 2005 |
Efonidipine reduces proteinuria and plasma aldosterone in patients with chronic glomerulonephritis.
Topics: Adult; Aged; Aldosterone; Amlodipine; Blood Pressure; Calcium Channel Blockers; Calcium Channels, L-Type; Calcium Channels, T-Type; Chronic Disease; Cross-Over Studies; Dihydropyridines; Female; Glomerulonephritis; Humans; Male; Middle Aged; Nitrophenols; Organophosphorus Compounds; Proteinuria | 2007 |
The effect of amlodipine and the combination of amlodipine and enalapril on the renin-angiotensin-aldosterone system in the dog.
Topics: Administration, Oral; Aldosterone; Amlodipine; Animals; Antihypertensive Agents; Blood Pressure; Blood Urea Nitrogen; Dogs; Drug Therapy, Combination; Enalapril; Heart Rate; Male; Renin-Angiotensin System | 2007 |
Comparison of the effects of efonidipine and amlodipine on aldosterone in patients with hypertension.
Topics: Aged; Aged, 80 and over; Aldosterone; Amlodipine; Blood Pressure; Calcium Channel Blockers; Calcium Channels, L-Type; Calcium Channels, T-Type; Dihydropyridines; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Natriuretic Peptide, Brain; Nitrophenols; Norepinephrine; Organophosphorus Compounds | 2007 |
Long-term effect of efonidipine therapy on plasma aldosterone and left ventricular mass index in patients with essential hypertension.
Topics: Aged; Aldosterone; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Dihydropyridines; Female; Humans; Hypertension; Hypertrophy, Left Ventricular; Male; Middle Aged; Natriuretic Peptide, Brain; Nitrophenols; Organophosphorus Compounds; Renin; Time Factors | 2009 |
CYP2C9 genotype modifies activity of the renin-angiotensin-aldosterone system in hypertensive men.
Topics: Adult; Aldosterone; Amlodipine; Antihypertensive Agents; Aryl Hydrocarbon Hydroxylases; Bisoprolol; Cross-Over Studies; Cytochrome P-450 CYP2C9; Double-Blind Method; Drug Resistance; Electrolytes; Gene Frequency; Genotype; Humans; Hypertension, Renal; Losartan; Male; Middle Aged; Placebos; Renin; Renin-Angiotensin System | 2009 |
Protective effects of efonidipine, a T- and L-type calcium channel blocker, on renal function and arterial stiffness in type 2 diabetic patients with hypertension and nephropathy.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Aged; Aldosterone; Amlodipine; Arteries; Calcium Channel Blockers; Calcium Channels, L-Type; Calcium Channels, T-Type; Deoxyguanosine; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Dihydropyridines; Female; Glycated Hemoglobin; Humans; Hypertension; Kidney; Lipids; Male; Middle Aged; Nitrophenols; Organophosphorus Compounds | 2009 |
Effects of efonidipine, an L- and T-type calcium channel blocker, on the renin-angiotensin-aldosterone system in chronic hemodialysis patients.
Topics: Aged; Aldosterone; Amlodipine; Blood Pressure; Calcium Channel Blockers; Calcium Channels, L-Type; Calcium Channels, T-Type; Cross-Over Studies; Dihydropyridines; Female; Humans; Kidney Failure, Chronic; Male; Middle Aged; Nitrophenols; Organophosphorus Compounds; Renal Dialysis; Renin-Angiotensin System | 2010 |
A new-generation N/L-type calcium channel blocker leads to less activation of the renin-angiotensin system compared with conventional L type calcium channel blocker.
Topics: Aged; Albuminuria; Aldosterone; Amlodipine; Angiotensin I; Angiotensin II; Blood Pressure; Calcium Channel Blockers; Cross-Over Studies; Dihydropyridines; Dose-Response Relationship, Drug; Female; Humans; Hypertension; Male; Middle Aged; Renin; Renin-Angiotensin System | 2010 |
Role of plasma aldosterone concentration in regression of left-ventricular mass following antihypertensive medication.
Topics: Adult; Aged; Aldosterone; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Female; Humans; Hypertension; Hypertrophy, Left Ventricular; Losartan; Male; Middle Aged; Ventricular Dysfunction, Left | 2011 |
Benidipine reduces albuminuria and plasma aldosterone in mild-to-moderate stage chronic kidney disease with albuminuria.
Topics: Aged; Albuminuria; Aldosterone; Amlodipine; Angiotensin Receptor Antagonists; Blood Pressure; Calcium Channel Blockers; Chronic Disease; Diabetic Nephropathies; Dihydropyridines; Female; Glomerular Filtration Rate; Glomerulonephritis; Humans; Hypertension; Male; Middle Aged; Nephrosclerosis; Potassium; Severity of Illness Index; Sodium | 2011 |
Pharmacokinetic interaction of fimasartan, a new angiotensin II receptor antagonist, with amlodipine in healthy volunteers.
Topics: Adult; Aldosterone; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Biphenyl Compounds; Blood Pressure; Calcium Channel Blockers; Cross-Over Studies; Dose-Response Relationship, Drug; Drug Interactions; Humans; Male; Metabolic Clearance Rate; Pyrimidines; Renin; Tetrazoles; Young Adult | 2011 |
Additive renoprotective effects of aliskiren on angiotensin receptor blocker and calcium channel blocker treatments for type 2 diabetic patients with albuminuria.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Adult; Aged; Albuminuria; Aldosterone; Amides; Amlodipine; Angiotensin II Type 2 Receptor Blockers; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Calcium Channel Blockers; Deoxyguanosine; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Fatty Acid-Binding Proteins; Female; Fumarates; Glomerular Filtration Rate; Glycated Hemoglobin; Humans; Male; Middle Aged; Renin; Telmisartan; Young Adult | 2012 |
L/N-type calcium channel blocker cilnidipine reduces plasma aldosterone, albuminuria, and urinary liver-type fatty acid binding protein in patients with chronic kidney disease.
Topics: Aged; Albuminuria; Aldosterone; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Biomarkers; Blood Pressure; Calcium Channel Blockers; Calcium Channels, L-Type; Calcium Channels, N-Type; Creatinine; Dihydropyridines; Down-Regulation; Fatty Acid-Binding Proteins; Female; Humans; Hypertension; Japan; Linear Models; Male; Middle Aged; Multivariate Analysis; Prospective Studies; Renal Insufficiency, Chronic; Time Factors; Treatment Outcome | 2013 |
Long-term effects of irbesartan on plasma aldosterone concentration and left atrial volume in hypertensive patients.
Topics: Aged; Aldosterone; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Atrial Remodeling; Biphenyl Compounds; Blood Pressure; Calcium Channel Blockers; Female; Heart Atria; Humans; Hypertension; Irbesartan; Male; Middle Aged; Tetrazoles; Time Factors | 2014 |
Greater efficacy of aldosterone blockade and diuretic reinforcement vs. dual renin-angiotensin blockade for left ventricular mass regression in patients with resistant hypertension.
Topics: Adolescent; Adult; Aged; Aldosterone; Amiloride; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Biphenyl Compounds; Bisoprolol; Blood Pressure; Blood Pressure Determination; Diuretics; Drug Therapy, Combination; Female; Furosemide; Humans; Hypertension; Hypertrophy, Left Ventricular; Irbesartan; Male; Middle Aged; Mineralocorticoid Receptor Antagonists; Ramipril; Renin; Renin-Angiotensin System; Spironolactone; Tetrazoles; Young Adult | 2014 |
Striatin genotype-based, mineralocorticoid receptor antagonist-driven clinical trial: study rationale and design.
Topics: Adolescent; Adult; Aged; Aldosterone; Alleles; Amlodipine; Animals; Blood Pressure; Calmodulin-Binding Proteins; Clinical Trials as Topic; Eplerenone; Genetic Predisposition to Disease; Humans; Hypertension; Male; Membrane Proteins; Mice; Middle Aged; Mineralocorticoid Receptor Antagonists; Nerve Tissue Proteins; Polymorphism, Single Nucleotide; Receptors, Mineralocorticoid; Young Adult | 2021 |
Effects of Renin-Angiotensin-Aldosterone Inhibitors on Early Outcomes of Hypertensive COVID-19 Patients: A Randomized Triple-Blind Clinical Trial.
Topics: Aldosterone; Amlodipine; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Angiotensins; Antihypertensive Agents; Carvedilol; COVID-19; Humans; Hypertension; Iran; Mineralocorticoid Receptor Antagonists; Renin | 2021 |
22 other study(ies) available for amlodipine and aldosterone
Article | Year |
---|---|
Differential effect of chronic inhibition of calcium channel and angiotensin II type 1-receptor on aldosterone synthesis in spontaneously hypertensive rats.
Topics: Adrenal Cortex; Aldosterone; Amlodipine; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Blood Chemical Analysis; Blood Pressure; Body Weight; Calcium Channel Blockers; Calcium Channels; Cholesterol Side-Chain Cleavage Enzyme; Cytochrome P-450 CYP11B2; Heart Rate; Immunochemistry; Male; Organ Size; Potassium; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sodium; Tetrazoles; Zona Glomerulosa | 2000 |
Chronic treatment with amlodipine modulates adrenocortical angiotensin II receptors in spontaneously hypertensive rats.
Topics: Adrenal Cortex; Aldosterone; Amlodipine; Animals; Antihypertensive Agents; Hypertension; Male; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Renin; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Systole; Transcription, Genetic | 2001 |
Effects of long-acting calcium channel antagonists on neurohumoral factors: comparison of nifedipine coat-core with amlodipine.
Topics: Aged; Aged, 80 and over; Aldosterone; Amlodipine; Blood Pressure; Calcium Channel Blockers; Chemistry, Pharmaceutical; Chi-Square Distribution; Delayed-Action Preparations; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Neurotransmitter Agents; Nifedipine; Norepinephrine; Renin | 2003 |
Lessons in the diagnosis and management of Conn's syndrome.
Topics: Adrenalectomy; Adrenocortical Adenoma; Aldosterone; Amiloride; Amlodipine; Calcium Channel Blockers; Humans; Hydrocortisone; Male; Middle Aged; Spironolactone | 2007 |
Hypertension due to a renin-secreting juxtaglomerular cell tumor.
Topics: Adult; Aldosterone; Amlodipine; Antihypertensive Agents; Biomarkers; Humans; Hyperaldosteronism; Hypertension, Renal; Juxtaglomerular Apparatus; Kidney Neoplasms; Male; Nephrectomy; Renin; Treatment Outcome | 2008 |
Different effects of L/N-type and L-type calcium channel blockers on the renin-angiotensin-aldosterone system in SHR/Izm.
Topics: Aldosterone; Amlodipine; Angiotensin II; Animals; Calcium Channel Blockers; Calcium Channels, L-Type; Calcium Channels, N-Type; Conotoxins; Dihydropyridines; Humans; Male; Norepinephrine; Rats; Rats, Inbred SHR; Renin; Renin-Angiotensin System; Time Factors | 2009 |
Coupled calcium and zinc dyshomeostasis and oxidative stress in cardiac myocytes and mitochondria of rats with chronic aldosteronism.
Topics: Aldehydes; Aldosterone; Amlodipine; Animals; Calcium; Calcium Channel Blockers; Chronic Disease; Disease Models, Animal; Glutathione Peroxidase; Homeostasis; Hydrogen Peroxide; Hyperaldosteronism; Male; Metallothionein; Mineralocorticoid Receptor Antagonists; Mitochondria, Heart; Myocytes, Cardiac; Oxidative Stress; Rats; Rats, Sprague-Dawley; Spironolactone; Superoxide Dismutase; Tyrosine; Zinc | 2009 |
Disparate effects of eplerenone, amlodipine and telmisartan on podocyte injury in aldosterone-infused rats.
Topics: Albuminuria; Aldosterone; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Animals; Apoptosis; Benzimidazoles; Benzoates; Blotting, Western; Calcium Channel Blockers; Eplerenone; Immunoenzyme Techniques; Kidney Glomerulus; Male; Membrane Proteins; Mineralocorticoid Receptor Antagonists; Podocytes; Proteinuria; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Spironolactone; Telmisartan | 2011 |
Amlodipine suppressed cardiac gene expression of brain natriuretic peptide, transforming growth factor-β₁ and fibronectin mediated by aldosterone in male stroke-prone spontaneously hypertensive rats.
Topics: Aldosterone; Amlodipine; Angiotensin II; Animals; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Cardiotonic Agents; Fibronectins; Gene Expression Regulation; Heart; Hypertension; Male; Myocardium; Natriuretic Peptide, Brain; Rats; Rats, Inbred SHR; Renin; Renin-Angiotensin System; Transforming Growth Factor beta | 2010 |
Eplerenone potentiates protective effects of amlodipine against cardiovascular injury in salt-sensitive hypertensive rats.
Topics: Aldosterone; Amlodipine; Animals; Antihypertensive Agents; Blood Pressure; Carotid Arteries; Drug Therapy, Combination; Endothelium, Vascular; Eplerenone; Heart; Hypertension; Male; Mineralocorticoid Receptor Antagonists; Myocardium; Nitric Oxide Synthase Type III; Oxidative Stress; Proto-Oncogene Proteins c-akt; Rats; Rats, Inbred Dahl; Receptor, Angiotensin, Type 1; Sodium Chloride, Dietary; Spironolactone; Superoxides; Treatment Outcome | 2011 |
Impaired sodium excretion and salt-sensitive hypertension in corin-deficient mice.
Topics: Aldosterone; Amiloride; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Biomarkers; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Body Weight; Calcium Channel Blockers; Disease Models, Animal; Dose-Response Relationship, Drug; Homeostasis; Hypertension; Kidney; Losartan; Male; Mice; Mice, Knockout; Natriuresis; Renin; Serine Endopeptidases; Sodium Channel Blockers; Sodium Chloride, Dietary; Telemetry; Time Factors | 2012 |
Reduction of aldosterone production improves renal oxidative stress and fibrosis in diabetic rats.
Topics: Aldosterone; Amides; Amlodipine; Animals; Antihypertensive Agents; Blood Glucose; Blood Pressure; Cyclic GMP; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Dinoprost; Down-Regulation; Fibronectins; Fibrosis; Fumarates; Immunohistochemistry; Kidney; Male; Natriuresis; Nitric Oxide; Oxidative Stress; Rats; Rats, Sprague-Dawley; Time Factors | 2013 |
Transient prehypertensive treatment in spontaneously hypertensive rats: a comparison of losartan and amlodipine regarding long-term blood pressure, cardiac and renal protection.
Topics: Aldosterone; Amlodipine; Angiotensin II; Animals; Antihypertensive Agents; Blood Pressure; Cardiotonic Agents; Collagen; Gene Expression Regulation; Heart Ventricles; Hypertension; Hypertrophy, Left Ventricular; Kidney; Losartan; Male; Natriuretic Peptide, Brain; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Renin-Angiotensin System; Stroke Volume; Transforming Growth Factor beta1; Ultrasonography | 2012 |
Long-term prehypertension treatment with losartan effectively prevents brain damage and stroke in stroke-prone spontaneously hypertensive rats.
Topics: Aldosterone; Amlodipine; Angiotensin II; Animals; Apoptosis; Blood Pressure; Brain; Hypertension; Losartan; Male; Membrane Glycoproteins; NADPH Oxidase 2; NADPH Oxidases; Oxidative Stress; Prehypertension; Rats; Rats, Inbred SHR; Renin-Angiotensin System; Stroke; Superoxide Dismutase; Time Factors | 2014 |
Hypokalaemia in a hyperthyroid domestic shorthair cat with adrenal hyperplasia.
Topics: Adrenal Glands; Adrenocortical Hyperfunction; Aldosterone; Amlodipine; Animals; Carbimazole; Cat Diseases; Cats; Female; Hyperplasia; Hypertension; Hyperthyroidism; Hypokalemia; Mineralocorticoid Receptor Antagonists; Potassium; Ultrasonography | 2014 |
On the top of ARB N/L type Ca channel blocker leads to less elevation of aldosterone.
Topics: Aged; Aldosterone; Amlodipine; Angiotensin Receptor Antagonists; Blood Pressure; Calcium Channel Blockers; Calcium Channels, L-Type; Calcium Channels, N-Type; Dihydropyridines; Drug Combinations; Female; Humans; Hypertension; Male; Middle Aged; Renin-Angiotensin System; Valsartan | 2016 |
Evaluation of the inhibitory effects of telmisartan on drug-induced renin-angiotensin-aldosterone system activation in normal dogs.
Topics: Aldosterone; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Benzoates; Blood Pressure; Dogs; Female; Heart Rate; Renin-Angiotensin System; Telmisartan | 2018 |
The hypertensive child.
Topics: Abdominal Pain; Adrenocorticotropic Hormone; Aldosterone; Amlodipine; Antihypertensive Agents; Catecholamines; Child; Deprescriptions; Diarrhea; Dietary Approaches To Stop Hypertension; Exercise; Headache; Humans; Hydrocortisone; Hypertension; Male; Renal Artery; Renin; Ultrasonography, Doppler; Vomiting | 2019 |
Visualization of calcium channel blockers in human adrenal tissues and their possible effects on steroidogenesis in the patients with primary aldosteronism (PA).
Topics: Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Aldosterone; Amlodipine; Calcium Channel Blockers; Calcium Channels; Humans; Hyperaldosteronism | 2022 |
Circulating renin-angiotensin-aldosterone system activity in cats with systemic hypertension or cardiomyopathy.
Topics: Aldosterone; Amlodipine; Animals; Biomarkers; Cardiomyopathies; Cat Diseases; Cats; Furosemide; Hypertension; Renin; Renin-Angiotensin System | 2022 |
Efficacy of Antihypertensive Drugs of Different Classes After Renal Denervation in Spontaneously Hypertensive Rats.
Topics: Aldosterone; Amlodipine; Animals; Antihypertensive Agents; Bisoprolol; Blood Pressure; Cardiomyopathies; Denervation; Doxazosin; Hydrochlorothiazide; Hypertension; Kidney; Male; Rats; Rats, Inbred SHR; Renin; Sympathectomy | 2023 |
Concurrent disorders of cats with diabetes mellitus and arterial systolic hypertension.
Topics: Aldosterone; Amlodipine; Animals; Antihypertensive Agents; Cat Diseases; Cats; Diabetes Mellitus; Hypertension; Isolated Systolic Hypertension; Longitudinal Studies; Renal Insufficiency, Chronic; Retrospective Studies | 2023 |